Cargando...
Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia
BACKGROUND: In the absence of treatment, endometrial hyperplasia (EH) can progress to endometrial cancer, particularly in the presence of histologic nuclear atypia. The development of EH results from exposure of the endometrium to oestrogen unopposed by progesterone. Oral progestogens have been used...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2020
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8200645/ https://ncbi.nlm.nih.gov/pubmed/32909630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012658.pub2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|